In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Series C round brings over $100mm to RefleXion Medical

Executive Summary

Radiation technology firm RefleXion Medical Inc. raised $102.6mm through its Series C round. TPG's Rise Fund led and was joined by T. Rowe Price, GT Healthcare Capital Partners, and all existing investors including Sofinnova Partners, KCK Group, Venrock, Pfizer Venture Investments, and Johnson & Johnson Innovation – JJDC Inc. The company is developing its biology-guided radiotherapy system (BgRT), which uses a PET imaging agent and targeted therapeutic x-ray to deliver high doses of radiation to multiple lesion sites, while sparing surrounding healthy tissue. The company has now raised $166mm through three venture rounds.

Deal Industry
  • Medical Devices
Deal Status
  • Final
Deal Type
  • Financing
    • Venture Financing

Related Companies